Abstract: The system obtains a unique identifier of the vehicle and a unique identifier of a driver of the vehicle. The system generates an OTP using the unique identifier of the vehicle and the unique identifier of the driver of the vehicle and sends the OTP to the UE of the driver of the vehicle. The system authenticates the vehicle and the driver of the vehicle by receiving the OTP from the unique identifier of the UE. The system creates in a database an association between the unique identifier of the vehicle, the unique identifier of the driver of the vehicle, and the UE of the driver of the vehicle. The system detects that the UE is proximate to the parking garage where the vehicle is parked. Upon detecting that the UE is proximate to the parking garage, the system identifies the vehicle of the UE and delivers the vehicle.

Abstract: Described are dominant-negative receptor mutants of V-Set and Immunoglobulin domain containing 3 (VSIG3) receptors and V-Set and Immunoglobulin domain containing 8 (VSIG8) receptors and methods of making the same for use in applications drawn to modulating the downstream signal transduction effects of VSIG3 and VSIG8 and their corresponding ligands. The invention is drawn to use of the use of the dnVSIG3 and/or dnVSIG8 receptor mutants to mitigate immunosuppressive effects associated with functional forms of VSIG3 and/or VSIG8 in the presence of their cognate ligands.

Abstract: A motor vehicle having a mounting device for a tray for use on a steering wheel or steering wheel rim arranged in a tray support position, wherein the tray has at least one guide element on a mounting side arranged opposite a tray surface, and wherein the mounting device has a counter-guide clement corresponding to the at least one guide element.

Abstract: The system obtains a unique identifier of the vehicle and a unique identifier of a driver of the vehicle. The system generates an OTP using the unique identifier of the vehicle and the unique identifier of the driver of the vehicle and sends the OTP to the UE of the driver of the vehicle. The system authenticates the vehicle and the driver of the vehicle by receiving the OTP from the unique identifier of the UE. The system creates in a database an association between the unique identifier of the vehicle, the unique identifier of the driver of the vehicle, and the UE of the driver of the vehicle. The system detects that the UE is proximate to the parking garage where the vehicle is parked. Upon detecting that the UE is proximate to the parking garage, the system identifies the vehicle of the UE and delivers the vehicle.

Abstract: A disclosed charge pump includes first and second stages and, optionally, additional stage(s). The first stage receives a voltage input (Vin) at a first voltage (V1), CLK1 (GND, V1), and CLK1B (V1, GND), and outputs a first stage voltage output (Vout1) at a second voltage (V2) double V1. A second stage receives Vout1, CLK2 (V1, V2), and CLK2B (V2, V1, and outputs a second stage voltage output (Vout2) at a third voltage (V3) essentially triple V1, and so on. A clock driver supplies CLK1-CLK1B to the first stage and to a clock generator. The clock generator includes: a voltage level shifter, which receives CLK1 and CLK1B and outputs multiple level-shifted voltage output pulses; and a driving circuit, which receives specific ones of the output voltage pulses and outputs CLK2 and CLK2B to the second stage and, if needed, additional voltage level-shifted clock signal-inverted clock signal pairs to any additional stages.

Abstract: An access and mobility management function (AMF) of a server system can receive performance parameters and location information from a user device. The performance parameters can describe the quality of a wireless connection of the user device on the telecommunications network. The server system can determine a geographical space associated with the user device based on the location information of the user device. The server system can determine a quality factor for the geographical space associated with the user device. The quality factor indicates whether a user device located within the geographical space should be allocated with guaranteed bit rate (GBR) resources or non-guaranteed bit rate (non-GBR) resources. The AMF can transmit a message including the quality factor to a core network function of the server system. The core network function can optimize the allocation of GBR and non-GBR resources for the geographical space based on the quality factor.

Abstract: The system obtains data associated with a failed interaction between a UE and a wireless telecommunication network and makes a series of determinations based on the data, including missing connection summary parameters, missing signaling information, missing component carrier parameters, whether the node in the network is properly configured, whether an RF measurement matches an expected RF measurement, and whether a condition associated with a channel used in the failed interaction is satisfactory. The system provides the results of the determinations to the root cause analytics engine, which in turn, based on the results, determines a root cause associated with the failed interaction.

Abstract: A server system associated with a telecommunications network can determine a first location of a wireless device based on a cellular signal. The system determines whether the first location of the wireless device is within a predetermined distance from any entity location of multiple entity locations. The database can store location information for the multiple entities. The system can determine whether the wireless device has remained at the first location for longer than a threshold time based on the cellular signal received from the wireless device. In response to determining that the wireless device has remained at the first location for longer than the threshold time and that the first location of the wireless device is within the predetermined distance from a first entity associated with a first entity location, the wireless device can present information associated with the first entity to a user of the wireless device.

Abstract: Embodiments of the disclosure provide a customizable logic cells and related methods to form the same. A structure of the disclosure includes a first pair of complementary transistors connected in series between a first voltage node and a second voltage node. Each transistor of the first pair includes a gate coupled to a first input node. A second pair of complementary transistors is connected in series between the first voltage node and the second voltage node in an opposite orientation from the first pair of complementary transistors. Each transistor of the second pair includes a gate coupled to a second input node. An output line is coupled to a first electrical connection between the first pair complementary transistors and a second electrical connection between the second pair of complementary transistors.

Abstract: The present disclosure, among other things, provides technologies for oligonucleotide synthesis. In some embodiments, the present disclosure provides phosphoramidites and methods for synthesis thereof. In some embodiments, provided methods provides higher yields and/or purities. In some embodiments, provided methods remove byproducts without contact with an aqueous solution.

Abstract: The present disclosure provides novel and efficient methods and lentiviral vectors for manufacturing a population of immune cells engineered to express a Chimeric Antigen Receptor (CAR), an engineered T cell receptor (TCR), and/or a nucleic acid sequence encoding a polypeptide that enhances the immune cell function, or a functional derivative thereof in less than 72 hours; engineered cells generated by the methods, compositions comprising said cells and methods of treating a disease or condition using said cells.

Abstract: The present disclosure, among other things, provides technologies for synthesis, including reagents and methods for stereoselective synthesis. In some embodiments, the present disclosure provides compounds useful as chiral auxiliaries. In some embodiments, the present disclosure provides reagents and methods for oligonucleotide synthesis. In some embodiments, the present disclosure provides reagents and methods for chirally controlled preparation of oligonucleotides. In some embodiments, technologies of the present disclosure are particularly useful for constructing challenging internucleotidic linkages, providing high yields and stereoselectivity.

Abstract: The present disclosure provides novel and efficient methods and lentiviral vectors for manufacturing a population of immune cells engineered to express a Chimeric Antigen Receptor (CAR), an engineered T cell receptor (TCR), and/or a nucleic acid sequence encoding a polypeptide that enhances the immune cell function, or a functional derivative thereof in less than 72 hours; engineered cells generated by the methods, compositions comprising said cells and methods of treating a disease or condition using said cells.

Abstract: The present disclosure, among other things, provides technologies for oligonucleotide synthesis. In some embodiments, the present disclosure provides phosphoramidites and methods for synthesis thereof. In some embodiments, provided methods provides higher yields and/or purities. In some embodiments, provided methods remove byproducts without contact with an aqueous solution.

Abstract: Various techniques for dynamic path selection and data flow forwarding are disclosed. For example, various systems, processes, and computer program products for dynamic path selection and data flow forwarding are disclosed for providing dynamic path selection and data flow forwarding that can facilitate preserving/enforcing symmetry in data flows as disclosed with respect to various embodiments.

Abstract: Among other things, the present disclosure provides technologies for oligonucleotide preparation, particularly chirally controlled oligonucleotide preparation, which technologies provide greatly improved crude purity and yield, and significantly reduce manufacturing costs.

Abstract: The present disclosure, among other things, provides technologies for synthesis, including reagents and methods for stereoselective synthesis. In some embodiments, the present disclosure provides compounds useful as chiral auxiliaries. In some embodiments, the present disclosure provides reagents and methods for oligonucleotide synthesis. In some embodiments, the present disclosure provides reagents and methods for chirally controlled preparation of oligonucleotides. In some embodiments, technologies of the present disclosure are particularly useful for constructing challenging internucleotidic linkages, providing high yields and stereoselectivity.

Abstract: Products, compositions, systems, and methods for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The methods may be performed in situ in a non-invasive manner by placing a nanoparticle having a metallic shell on at least a fraction of a surface in a vicinity of a target structure in a subject and applying an initiation energy to a subject thus producing an effect on or change to the target structure directly or via a modulation agent. The nanoparticle is configured, upon exposure to a first wavelength ?1, to generate a second wavelength ?2 of radiation having a higher energy than the first wavelength ?1.

Abstract: The present disclosure provides modified oligonucleotides and compositions and methods thereof. In some embodiments, provided technologies comprise modified sugars and/or modified internucleotidic linkages. In some embodiments, the present disclosure provides technologies for preparing modified oligonucleotides. In some embodiments, the present disclosure provides chirally controlled oligonucleotide compositions and methods for their preparation and uses.

Abstract: The present invention provides methods of preparing compound of Formula (I), wherein the compounds are represented by the structure of Formula (I) wherein: R1 each is independently F, Cl, Br, I, OCH3, CN or NO2; R2 each is independently identical or different C1-C5 alkyl; n1 is an integer between 1 and 5; and n2 is an integer between 1 and 4.